Albuminuria Is an Appropriate Therapeutic Target in Patients with CKD

Gansevoort, 2009, Hermann Senator and albuminuria—forgotten pioneering work in the 19th century, Nephrol Dial Transplant, 24, 1057, 10.1093/ndt/gfn741

Williams, 1988, Renal pathology and proteinuria determine progression in untreated mild/moderate chronic renal failure, Q J Med, 67, 343

Johnson, 2011, Strengths and weaknesses of renal markers as risk factors and surrogate markers, Kidney Int, 79, 1272, 10.1038/ki.2011.61

Parving, 2015, Microalbuminuria: A parameter that has changed diabetes care, Diabetes Res Clin Pract, 107, 1, 10.1016/j.diabres.2014.10.014

Remuzzi, 1990, Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules?, Kidney Int, 38, 384, 10.1038/ki.1990.217

Abbate, 2006, How does proteinuria cause progressive renal damage?, J Am Soc Nephrol, 17, 2974, 10.1681/ASN.2006040377

Chen, 1997, Proteinuria and tubulointerstitial injury, Kidney Int Suppl, 61, S60

Okada, 2012, Histological predictors for renal prognosis in diabetic nephropathy in diabetes mellitus type 2 patients with overt proteinuria, Nephrology (Carlton, 17, 68, 10.1111/j.1440-1797.2011.01525.x

Birn, 2006, Renal albumin absorption in physiology and pathology, Kidney Int, 69, 440, 10.1038/sj.ki.5000141

Gekle, 2005, Renal tubule albumin transport, Annu Rev Physiol, 67, 573, 10.1146/annurev.physiol.67.031103.154845

Amsellem, 2010, Cubilin is essential for albumin reabsorption in the renal proximal tubule, J Am Soc Nephrol, 21, 1859, 10.1681/ASN.2010050492

Pollock, 2007, Albumin transport and processing by the proximal tubule: Physiology and pathophysiology, Curr Opin Nephrol Hypertens, 16, 359, 10.1097/MNH.0b013e3281eb9059

Birn, 2000, Cubilin is an albumin binding protein important for renal tubular albumin reabsorption, J Clin Invest, 105, 1353, 10.1172/JCI8862

Christensen, 2001, Megalin and cubilin: Synergistic endocytic receptors in renal proximal tubule, Am J Physiol Renal Physiol, 280, F562, 10.1152/ajprenal.2001.280.4.F562

Storm, 2013, Renal phenotypic investigations of megalin-deficient patients: Novel insights into tubular proteinuria and albumin filtration, Nephrol Dial Transplant, 28, 585, 10.1093/ndt/gfs462

Macconi, 2009, Proteasomal processing of albumin by renal dendritic cells generates antigenic peptides, J Am Soc Nephrol, 20, 123, 10.1681/ASN.2007111233

Morigi, 2002, Protein overload-induced NF-kappaB activation in proximal tubular cells requires H(2)O(2) through a PKC-dependent pathway, J Am Soc Nephrol, 13, 1179

Dixon, 1999, Activation of mitogenic pathways by albumin in kidney proximal tubule epithelial cells: Implications for the pathophysiology of proteinuric states, J Am Soc Nephrol, 10, 1487, 10.1681/ASN.V1071487

Drumm, 2002, Albumin induces NF-kappaB expression in human proximal tubule-derived cells (IHKE-1), Cell Physiol Biochem, 12, 187, 10.1159/000066278

Lee, 2003, Effects of pathophysiological concentrations of albumin on NHE3 activity and cell proliferation in primary cultures of human proximal tubule cells, Am J Physiol Renal Physiol, 285, F748, 10.1152/ajprenal.00442.2002

Wang, 1997, Induction of monocyte chemoattractant protein-1 in proximal tubule cells by urinary protein, J Am Soc Nephrol, 8, 1537, 10.1681/ASN.V8101537

Zoja, 1998, Protein overload stimulates RANTES production by proximal tubular cells depending on NF-kappa B activation, Kidney Int, 53, 1608, 10.1046/j.1523-1755.1998.00905.x

Vlachojannis, 2002, Endothelin-1 in the kidney and urine of patients with glomerular disease and proteinuria, Clin Nephrol, 58, 337, 10.5414/CNP58337

Zoja, 1995, Proximal tubular cell synthesis and secretion of endothelin-1 on challenge with albumin and other proteins, Am J Kidney Dis, 26, 934, 10.1016/0272-6386(95)90058-6

Whaley-Connell, 2007, Albumin activation of NAD(P)H oxidase activity is mediated via Rac1 in proximal tubule cells, Am J Nephrol, 27, 15, 10.1159/000098432

Diwakar, 2007, The role played by endocytosis in albumin-induced secretion of TGF-beta1 by proximal tubular epithelial cells, Am J Physiol Renal Physiol, 292, F1464, 10.1152/ajprenal.00069.2006

Goumenos, 2002, Transforming growth factor-beta(1) in the kidney and urine of patients with glomerular disease and proteinuria, Nephrol Dial Transplant, 17, 2145, 10.1093/ndt/17.12.2145

Stephan, 2004, Albumin stimulates the accumulation of extracellular matrix in renal tubular epithelial cells, Am J Nephrol, 24, 14, 10.1159/000075347

Roscioni, 2014, Microalbuminuria: Target for renoprotective therapy PRO, Kidney Int, 86, 40, 10.1038/ki.2013.490

van der Velde, 2009, Screening for albuminuria identifies individuals at increased renal risk, J Am Soc Nephrol, 20, 852, 10.1681/ASN.2008060655

Gansevoort, 2011, Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts, Kidney Int, 80, 93, 10.1038/ki.2010.531

Agarwal, 2014, A prospective study of multiple protein biomarkers to predict progression in diabetic chronic kidney disease, Nephrol Dial Transplant, 29, 2293, 10.1093/ndt/gfu255

Hallan, 2009, Combining GFR and albuminuria to classify CKD improves prediction of ESRD, J Am Soc Nephrol, 20, 1069, 10.1681/ASN.2008070730

Rigalleau, 2007, Normoalbuminuric renal-insufficient diabetic patients: A lower-risk group, Diabetes Care, 30, 2034, 10.2337/dc07-0140

Packer, 1991, Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group, N Engl J Med, 325, 1468, 10.1056/NEJM199111213252103

Kramer, 2006, Sodium intake modifies the negative prognostic value of renal damage prior to treatment with ACE inhibitors on proteinuria induced by adriamycin, Nephron Physiol, 103, 43, 10.1159/000090222

Lambers Heerspink, 2012, Moderation of dietary sodium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockers, Kidney Int, 82, 330, 10.1038/ki.2012.74

Vegter, 2012, Sodium intake, ACE inhibition, and progression to ESRD, J Am Soc Nephrol, 23, 165, 10.1681/ASN.2011040430

Inker, 2014, Early change in proteinuria as a surrogate end point for kidney disease progression: An individual patient meta-analysis, Am J Kidney Dis, 64, 74, 10.1053/j.ajkd.2014.02.020

Hou, 2007, Renoprotection of Optimal Antiproteinuric Doses (ROAD) Study: A randomized controlled study of benazepril and losartan in chronic renal insufficiency, J Am Soc Nephrol, 18, 1889, 10.1681/ASN.2006121372

Navarro-González, 2015, Effect of Pentoxifylline on Renal Function and Urinary Albumin Excretion in Patients with Diabetic Kidney Disease: The PREDIAN Trial, J Am Soc Nephrol, 26, 220, 10.1681/ASN.2014010012

Group, 1995, Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial, Kidney Int, 47, 1703, 10.1038/ki.1995.236

de Boer, 2011, Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes, N Engl J Med, 365, 2366, 10.1056/NEJMoa1111732

Perkovic, 2013, Intensive glucose control improves kidney outcomes in patients with type 2 diabetes, Kidney Int, 83, 517, 10.1038/ki.2012.401

Klahr, 1994, The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease, N Engl J Med, 330, 877, 10.1056/NEJM199403313301301

Levey, 1999, Dietary protein restriction and the progression of chronic renal disease: What have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study group, J Am Soc Nephrol, 10, 2426, 10.1681/ASN.V10112426

Ruggenenti, 2008, Role of remission clinics in the longitudinal treatment of CKD, J Am Soc Nephrol, 19, 1213, 10.1681/ASN.2007090970

de Zeeuw, 2004, Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: Lessons from RENAAL, Kidney Int, 65, 2309, 10.1111/j.1523-1755.2004.00653.x

Xie, 2011, High level of proteinuria during treatment with renin-angiotensin inhibitors is a strong predictor of renal outcome in nondiabetic kidney disease, J Clin Pharmacol, 51, 1025, 10.1177/0091270010377502

Mann, 2008, Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): A multicentre, randomised, double-blind, controlled trial, Lancet, 372, 547, 10.1016/S0140-6736(08)61236-2

Parving, 2012, Cardiorenal end points in a trial of aliskiren for type 2 diabetes, N Engl J Med, 367, 2204, 10.1056/NEJMoa1208799

Fried, 2013, Combined angiotensin inhibition for the treatment of diabetic nephropathy, N Engl J Med, 369, 1892, 10.1056/NEJMoa1303154

Jafar, 2001, Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease, Kidney Int, 60, 1131, 10.1046/j.1523-1755.2001.0600031131.x

Tobe, 2011, Cardiovascular and renal outcomes with telmisartan, ramipril, or both in people at high renal risk: Results from the ONTARGET and TRANSCEND studies, Circulation, 123, 1098, 10.1161/CIRCULATIONAHA.110.964171

Lambers Heerspink, 2011, ONTARGET still OFF-TARGET?, Circulation, 123, 1049, 10.1161/CIRCULATIONAHA.111.018382

Lassere, 2008, The Biomarker-Surrogacy Evaluation Schema: A review of the biomarker-surrogate literature and a proposal for a criterion-based, quantitative, multidimensional hierarchical levels of evidence schema for evaluating the status of biomarkers as surrogate endpoints, Stat Methods Med Res, 17, 303, 10.1177/0962280207082719

Moynihan, 2011, Surrogates under scrutiny: Fallible correlations, fatal consequences, BMJ, 343, d5160, 10.1136/bmj.d5160

Atkins, 2005, Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy, Am J Kidney Dis, 45, 281, 10.1053/j.ajkd.2004.10.019

Lea, 2005, The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: Results of the African American study of kidney disease and hypertension, Arch Intern Med, 165, 947, 10.1001/archinte.165.8.947

Ruggenenti, 2003, Retarding progression of chronic renal disease: The neglected issue of residual proteinuria, Kidney Int, 63, 2254, 10.1046/j.1523-1755.2003.00033.x

Roscioni, 2013, A urinary peptide biomarker set predicts worsening of albuminuria in type 2 diabetes mellitus, Diabetologia, 56, 259, 10.1007/s00125-012-2755-2

Schmieder, 2011, Changes in albuminuria predict mortality and morbidity in patients with vascular disease, J Am Soc Nephrol, 22, 1353, 10.1681/ASN.2010091001